| Eravacycline: a comprehensive review of in vitro activity, clinical efficacy, and real-world applications PY Huang, CK Hsu, HJ Tang, CC Lai Expert Review of Anti-infective Therapy 22 (6), 387-398, 2024 | | 2024 |
| Association Between Rheumatoid Arthritis and the Risk of Lung Cancer CK Hsu, CC Lai Journal of Thoracic Oncology 19 (6), e9, 2024 | | 2024 |
| Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in Asia-Pacific region CC Lai, CC Hsueh, CK Hsu, YW Tsai, PR Hsueh International Journal of Antimicrobial Agents, 107205, 2024 | 1 | 2024 |
| The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants CK Hsu, WH Hsu, BW Shiau, YW Tsai, JY Wu, TH Liu, PY Huang, ... Expert Review of Anti-infective Therapy, 1-8, 2024 | | 2024 |
| Evaluation of three brands of Mueller-Hinton media for broth microdilution method to determine the susceptibility of multidrug-resistant Gram-negative bacilli against eravacycline. CK Hsu, CC Lai, CC Chen, HJ Chen, HJ Tang International Journal of Antimicrobial Agents, 107117-107117, 2024 | | 2024 |
| Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients SF Tey, YW Tsai, JY Wu, TH Liu, MH Chuang, WH Hsu, PY Huang, ... Frontiers in Public Health 12, 1337646, 2024 | 1 | 2024 |
| Clinical efficacy and safety of interleukin-1 blockade in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials SH Lan, CK Hsu, SP Chang, LC Lu, CC Lai Annals of Medicine 55 (1), 2208872, 2023 | 2 | 2023 |
| Assessing risk factors for COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease PY Huang, CC Lai, CK Hsu Journal of medical virology 95 (12), e29281, 2023 | | 2023 |
| Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials TYT Chen, CK Hsu, SC Shih, TS Weng, HJ Tang, CC Lai International Journal of Antimicrobial Agents 62 (2), 106844, 2023 | 4 | 2023 |
| Ceftobiprole medocaril for the treatment of pneumonia WH Hsu, CK Hsu, CC Lai Expert Review of Anti-infective Therapy 21 (6), 551-563, 2023 | 3 | 2023 |
| Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysis PY Huang, CK Hsu, TH Liu, JY Wu, HJ Tang, YW Tsai, CC Lai, YH Chang Journal of Global Antimicrobial Resistance 33, 201-207, 2023 | 1 | 2023 |
| Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis CK Hsu, WW Tsai, CC Lai JAMA 329 (8), 684-685, 2023 | | 2023 |
| The confounding effect of vaccine status CK Hsu, CC Lai Clinical Infectious Diseases 76 (4), 774-774, 2023 | 1 | 2023 |
| Multisystem inflammatory syndrome in adults: Characteristics, treatment, and outcomes CC Lai, CK Hsu, SC Hsueh, MY Yen, WC Ko, PR Hsueh Journal of Medical Virology 95 (2), e28426, 2023 | 13 | 2023 |
| Long COVID: An inevitable sequela of SARS-CoV-2 infection CC Lai, CK Hsu, MY Yen, PI Lee, WC Ko, PR Hsueh Journal of Microbiology, Immunology and Infection 56 (1), 1-9, 2023 | 75 | 2023 |
| Different Indications Between Fluoroquinolone and Amoxicillin. CK Hsu, CC Lai Clinical Infectious Diseases 76 (2), 2023 | 1 | 2023 |
| Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials SH Lan, CK Hsu, CC Lai, SP Chang, LC Lu, SH Hung, WT Lin Annals of Medicine 54 (1), 1956-1965, 2022 | 14 | 2022 |
| Comment on Pietropaolo et al. Incidence of an insulin-requiring hyperglycemic syndrome in SARS-CoV-2–infected young individuals: is it type 1 diabetes? Diabetes 2022; 71: 2656–2663 CK Hsu, CC Lai Diabetes 71 (12), e18-e18, 2022 | 2 | 2022 |
| Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis CK Hsu, CM Chao, CC Lai Journal of Microbiology, Immunology, and Infection 55 (6), 1129, 2022 | 5 | 2022 |
| Infection indication and severity CK Hsu, CC Lai Kidney international 102 (5), 1191, 2022 | | 2022 |
